CNTN — Canton Strategic Holdings Share Price
0.000.00%
Last trade - 00:00- $191.29m
- $183.84m
- 30
- 11
- 73
- 31
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 30.77 | ||
| Price to Tang. Book | 30.77 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -167.98% | ||
| Return on Equity | -225.01% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Canton Strategic Holdings, Inc., formerly Tharimmune, Inc., is advancing institutional blockchain adoption to drive the digitization of financial markets. In addition to driving value through activities on the Canton Network, the Company operates a Super Validator, ensuring safe and secure transactions across the Network. The Company also operates a clinical-stage biotech research and development arm. Its lead clinical asset, GV104, is being developed for a specific indication via a 505(b)2 pathway for respiratory and/or nervous system depression in military personnel and chemical incident responders who may encounter high-potency opioids. The expanded pipeline includes other indications for GV104 and GV023, a new approach to autoimmune diseases, as well as an early-stage multispecific biologic platform.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- September 30th, 2025
- Incorporated
- July 16th, 2019
- Public Since
- January 12th, 2022
- No. of Shareholders
- 39
- No. of Employees
- 2
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 37,729,847
- Address
- 1200 Route 22 East, BRIDGEWATER, 08807
- Web
- https://www.cantonstrategic.com
- Phone
- +1 3026457400
- Auditors
- ROSENBERG RICH BAKER BERMAN, P.A.
Upcoming Events for CNTN
Tharimmune Inc Annual Shareholders Meeting
Similar to CNTN
ABVC Biopharma
NASDAQ Capital Market
Acesis Holdings
NASDAQ Capital Market
Achieve Life Sciences
NASDAQ Capital Market
Aclarion
NASDAQ Capital Market
Acurx Pharmaceuticals
NASDAQ Capital Market
FAQ
What is the Canton Strategic Holdings share price?
As of Today at 18:47 UTC, shares in Canton Strategic Holdings are trading at $5.02. This share price information is delayed by 15 minutes.
How has the Canton Strategic Holdings share price performed this year?
Shares in Canton Strategic Holdings last closed at $5.02 and the price had moved by +232.45% over the past 365 days. In terms of relative price strength the Canton Strategic Holdings share price has outperformed the S&P500 Index by +182.06% over the past year.
What are the analyst and broker recommendations for Canton Strategic Holdings?
The overall consensus recommendation for Canton Strategic Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Canton Strategic Holdings dividend yield?
Canton Strategic Holdings does not currently pay a dividend.
Does Canton Strategic Holdings pay a dividend?
Canton Strategic Holdings does not currently pay a dividend.
When does Canton Strategic Holdings next pay dividends?
Canton Strategic Holdings does not currently pay a dividend.
How do I buy Canton Strategic Holdings shares?
To buy shares in Canton Strategic Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Canton Strategic Holdings?
As of the previous close price of $5.02, shares in Canton Strategic Holdings had a market capitalisation of $191.29m.
Where are Canton Strategic Holdings shares listed?
Here are the trading details for Canton Strategic Holdings:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: CNTN
What kind of share is Canton Strategic Holdings?
Based on an overall assessment of its quality, value and momentum Canton Strategic Holdings is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Canton Strategic Holdings share price forecast for 2026?
The analyst consensus target price for shares in Canton Strategic Holdings is $4.95. That is 1.38% below the last closing price of $5.02.
Analysts covering Canton Strategic Holdings currently have a consensus Earnings Per Share (EPS) forecast of -$7.06 for the next financial year.
Find out moreWhat is the trend in the Canton Strategic Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Canton Strategic Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -21.65%.
As of the last closing price of $5.02, shares in Canton Strategic Holdings were trading +83.68% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Canton Strategic Holdings PE Ratio?
The Canton Strategic Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $5.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Canton Strategic Holdings?
We do not have data on Canton Strategic Holdings' directors